391 material Form 8-K filings that 340 companies we cover made with the SEC in July 2024, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
CorVel reported results for the quarter ended June 30, 2024, in a press release furnished as Exhibit 99.1. Revenue rose to $212 million from $190 million a year earlier, net income rose to $21.6 million from $19.8 million, and diluted earnings per share rose to $1.25 from $1.14. Revenue, profit and per-share earnings all improved year over year.
Revenue of $212 million for the quarter, up from $190 million in the June 2023 quarter
Diluted EPS of $1.25, compared with $1.14 a year earlier
Gross profit of $48.2 million at a 22.7% gross margin, up from $41.9 million
Repurchased $9.5 million of common stock; ended the quarter with $132 million in cash and no borrowings
NewMarket reported second-quarter 2024 net income of $111.6 million, or $11.63 per share, up from $99.6 million, or $10.36 per share, a year earlier. Total net sales rose to $710.2 million from $685.1 million, with the increase including its newly acquired AMPAC specialty materials business, while petroleum additives sales fell slightly. The results are a routine quarterly update, and the filing does not include new guidance.
Q2 2024 net income was $111.6 million, or $11.63 per share, versus $99.6 million, or $10.36 per share, in Q2 2023.
Petroleum additives operating profit was $147.8 million, up from $132.1 million, mainly due to lower raw material and operating costs and higher shipments, partly offset by lower selling prices.
Petroleum additives sales were $669.8 million, down from $684.0 million, while specialty materials (AMPAC) added $38.0 million in sales.
Net Debt to EBITDA was 1.6 as of June 30, 2024, after the AMPAC acquisition completed on January 16, 2024; long-term debt was $1.17 billion.
Centerspace reported second-quarter 2024 results and raised the midpoint of its 2024 Core FFO per diluted share outlook, narrowing the range to $4.78 to $4.92 from $4.74 to $4.92. Q2 net loss was $0.19 per diluted share, compared with a $0.23 loss a year earlier, while Core FFO per diluted share was $1.27 versus $1.28 in the prior-year quarter.
Updated 2024 Core FFO per diluted share outlook: $4.78 to $4.92, up from $4.74 to $4.92; net income per diluted share outlook raised to $(1.21) to $(1.01) from $(1.34) to $(1.10)
Q2 2024 net loss of $0.19 per diluted share vs. $0.23 loss in Q2 2023; Q2 Core FFO of $1.27 per diluted share vs. $1.28
Six-month Core FFO per diluted share rose 5.5% to $2.49; same-store NOI rose 2.4% in Q2 2024 year over year
Unsecured credit facility maturity extended to July 2028 on July 26, 2024; borrowing capacity stayed at $250.0 million
COPT Defense Properties reported results for the quarter ended June 30, 2024, with net income of $36.4 million, up from $31.6 million in the same quarter of 2023. Diluted FFO per share rose to $0.64 from $0.60, and the company's quarterly dividend per common share was $0.295, up from $0.285 a year earlier.
Q2 2024 total revenues were $187.3 million, compared with $169.2 million in Q2 2023.
Diluted EPS was $0.31, compared with $0.27 in Q2 2023. Net income was $36.4 million.
NOI from real estate operations was $105.4 million, compared with $95.0 million in Q2 2023.
Dividend per common share was $0.295 for the quarter, compared with $0.285 a year earlier.
CNO Financial Group reported second-quarter 2024 net income of $116.3 million, or $1.06 per diluted share, up from $73.7 million, or $0.64 per diluted share, a year earlier. Net operating income rose to $114.6 million, or $1.05 per diluted share, and the company said it is raising full-year guidance on earnings and cash flow. The company returned $77.2 million to shareholders in the quarter through buybacks and dividends.
Net income of $116.3 million, or $1.06 per diluted share, in 2Q24 versus $73.7 million, or $0.64, in 2Q23
Net operating income of $114.6 million, or $1.05 per diluted share, in 2Q24 versus $62.3 million, or $0.54, in 2Q23
Full-year guidance raised on earnings and cash flow
Repurchased $60.0 million of common stock in 2Q24; 106.5 million shares outstanding at June 30, 2024
Element Solutions reported second-quarter 2024 net sales of $613 million, up 5% from a year earlier, and net income of $93 million versus $30 million in the same quarter of 2023. GAAP diluted EPS was $0.38 compared with $0.11, and adjusted EBITDA rose 16% to $135 million. The company also said it raised its full-year 2024 adjusted EBITDA guidance to $530 million to $545 million, which supports the earnings trend for shareholders.
Net sales $613 million, up 5% reported and 4% organic; Electronics up 10% to $392 million
GAAP diluted EPS $0.38 vs $0.11; adjusted EPS $0.36 vs $0.31 a year earlier
Adjusted EBITDA $135 million, up 16%; Industrial & Specialty net sales down 4% to $221 million
Full-year 2024 adjusted EBITDA guidance raised to $530 million to $545 million; free cash flow expected $280 million to $300 million
SBA Communications reported second-quarter 2024 total revenues of $660.5 million, down 2.7%, and net income of $159.5 million, or $1.51 per diluted share, down from $1.87 a year earlier. The company also lowered its full-year 2024 revenue and Adjusted EBITDA outlook, which weighs on shareholders, while declaring a $0.98 quarterly dividend.
Q2 2024 total revenues were $660.5 million, down from $678.5 million; net income was $159.5 million, or $1.51 per diluted share, versus $202.0 million, or $1.87, in Q2 2023
Net income included a $66.2 million after-tax loss on currency remeasurement of intercompany loans
Full-year 2024 total revenue outlook is now $2,642.0 million to $2,672.0 million, a $20.0 million cut at the midpoint; Adjusted EBITDA outlook is $1,876.0 million to $1,896.0 million, down $13.0 million at the midpoint
Quarterly dividend of $0.98 per share is payable September 18, 2024 to holders of record on August 22, 2024
Merchants Bancorp reported second quarter 2024 net income of $76.4 million, or $1.49 per diluted share, up 17% and 14% from the second quarter of 2023 but down 12% and 17% from the first quarter of 2024. Total assets reached $18.2 billion and tangible book value per share rose 30% year over year to $31.27.
Net income of $76.4 million, up 17% from $65.3 million a year earlier and down 12% from $87.1 million in Q1 2024
Diluted EPS of $1.49, up from $1.31 a year earlier and down from $1.80 in Q1 2024
Total assets of $18.2 billion at June 30, 2024; tangible book value per share of $31.27, up 30% from $24.14
Non-performing loans rose to $143.5 million, or 1.30% of gross loans, from $131.8 million (1.22%) at March 31, 2024
AMERISAFE reported second-quarter 2024 net income of $11.0 million, down 29.7% from $15.6 million a year earlier, and diluted EPS of $0.57, down from $0.81. Net premiums earned rose 4.6% to $68.6 million, but higher loss and expense costs cut underwriting profit by 31.2% to $6.5 million, so shareholders saw lower per-share earnings even as the insurer wrote more business.
Diluted EPS was $0.57 for the quarter, versus $0.81 in Q2 2023; operating EPS was $0.58, versus $0.73.
Net premiums earned rose 4.6% to $68.6 million, while the net combined ratio worsened to 90.5% from 85.4%.
Favorable prior accident year reserve development reduced loss expenses by $8.1 million.
The Board declared a quarterly dividend of $0.37 per share on July 26, 2024, payable September 20, 2024; a conference call is set for July 30, 2024.
Corcept Therapeutics reported second-quarter 2024 revenue of $163.8 million, up 39% from a year earlier, and raised its full-year 2024 revenue guidance to $640 million to $670 million from $620 million to $650 million. Diluted earnings per share were $0.32, compared with $0.25 in the second quarter of 2023, though operating expenses rose to $128.2 million from $88.1 million.
Q2 2024 revenue of $163.8 million, versus $117.7 million in Q2 2023
Diluted EPS of $0.32 versus $0.25; net income of $35.5 million versus $27.5 million
2024 revenue guidance raised to $640 million to $670 million from $620 million to $650 million
Cash and investments of $492.5 million at June 30, 2024, up from $451.0 million at March 31, 2024
Rambus reported second-quarter 2024 results for the period ended June 30, 2024, with GAAP revenue of $132.1 million, up from $119.8 million a year earlier, and operating income of $40.3 million, up from $11.7 million. Net income fell to $36.1 million, or $0.33 per diluted share, from $168.9 million, or $1.51, a year earlier, when the company recorded an income tax benefit of $155.3 million. Shareholders get higher revenue and operating income, but reported earnings declined against a prior-year period that included that tax benefit, and the company said it expects a strong third quarter.
GAAP revenue was $132.1 million versus $119.8 million in Q2 2023; product revenue was $56.7 million and royalties were $56.4 million.
Net income was $36.1 million, or $0.33 per diluted share, versus $168.9 million, or $1.51, in Q2 2023, which included a $155.3 million income tax benefit.
Cash from operating activities was $70.4 million, versus $50.4 million a year earlier; cash and marketable securities totaled $432.9 million at June 30, 2024.
Third-quarter 2024 outlook calls for product revenue of $62 million to $68 million and licensing billings of $60 million to $66 million; full revenue guidance will be discussed on the conference call.
Lattice Semiconductor reported second-quarter 2024 revenue of $124.1 million, down 11.9% from the first quarter and 34.7% from a year earlier, with GAAP diluted earnings of $0.16 per share. The company guided third-quarter 2024 revenue to between $117 million and $137 million, and interim CEO Esam Elashmawi said the industry is starting to show signs of improvement after a period of inventory normalization.
Q2 2024 revenue was $124.1 million, down 11.9% from Q1 2024 and down 34.7% from Q2 2023.
GAAP diluted EPS was $0.16 versus $0.11 in Q1 2024 and $0.36 in Q2 2023; non-GAAP diluted EPS was $0.23 versus $0.29 in Q1 2024.
Q3 2024 outlook: revenue of $117 million to $137 million, non-GAAP gross margin of 69.0% plus or minus 1%, and non-GAAP operating expenses of $53 million to $55 million.
The company repurchased shares for the fifteenth consecutive quarter, with $30.0 million of buybacks in the first half of 2024.
At its July 26, 2024 annual meeting, Cirrus Logic stockholders approved an amended and restatement of the 2018 Long Term Incentive Plan, adding 2,670,000 shares and extending the plan to July 26, 2034. Stockholders also re-elected all seven directors, ratified Ernst & Young LLP as auditor, and approved an officer exculpation charter amendment.
Amended LTIP adds 2,670,000 shares and extends the plan's expiration to July 26, 2034.
Plan amendment passed with 38,086,580 votes for and 6,375,658 against.
Officer exculpation amendment to the certificate of incorporation passed with 37,017,286 votes for and 7,443,734 against.
BancFirst's board appointed Kim Ingram, owner and CEO of Kelly Jewelers in Weatherford, Oklahoma, as a director, effective at the September 26, 2024 board meeting. She will also join the BancFirst bank board and the Independent Directors' Committee, and she is up for election at the May 2025 annual meeting.
Kim Ingram appointed director by the board on July 25, 2024, effective September 26, 2024
Term expires at the May 2025 annual shareholder meeting, when she will stand for re-election
Compensation follows the outside director fee schedule; restricted stock units to be granted at a later date
Filing states no arrangements with other persons for selection and no related-party transactions requiring disclosure
Minerals Technologies furnished the transcript and slides from its July 26, 2024 second-quarter earnings call as Exhibits 99.1 and 99.2, because a third-party webcast problem meant some listeners could not hear part of the audio. The call showed higher operating income and earnings per share excluding special items, offset by $34 million in special charges, mainly a $30 million provision for a credit loss on a line of credit to BMI Oldco, the entity formerly known as BMI.
Q2 2024 sales were $541 million, up 1% on an underlying basis; operating income was $85 million, up 20%, with operating margin of 15.7%.
Earnings per share were $1.65 excluding special items, up 26% from the prior year; special charges totaled $34 million.
The $34 million in special charges mainly reflects a $30 million provision for credit loss on a committed line of credit to BMI Oldco, of which $5 million has been loaned so far.
For Q3 2024, the company expects sales of $535 million to $545 million, operating income of $77 million to $80 million, and EPS of $1.50 to $1.55.
Revvity reported second-quarter 2024 revenue of $692 million, down from $709 million a year earlier, while GAAP EPS rose to $0.45 from $0.28 and adjusted EPS from continuing operations was $1.22 versus $1.21. The company raised its full-year 2024 adjusted EPS guidance to $4.70-$4.80 and set revenue guidance at $2.77-$2.79 billion, citing currency changes and assumed 2% organic revenue growth. Shareholders see higher profit measures alongside a lower top line, with Life Sciences revenue down 7%.
Q2 2024 revenue was $692 million versus $709 million a year earlier; reported revenue fell 2% and organic revenue fell 1%.
GAAP EPS was $0.45 versus $0.28; adjusted EPS from continuing operations was $1.22 versus $1.21.
Full-year 2024 adjusted EPS guidance raised to $4.70-$4.80; revenue guidance updated to $2.77-$2.79 billion.
Life Sciences revenue fell 7% to $314 million; Diagnostics revenue rose 1% to $378 million.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.